CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: thioridazine
Accession: CHEBI:9566
browse the term
Definition: A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Synonyms: related_synonym: 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; Mallorol; Malloryl; Meleril; Mellaril; Mellaril-S; Mellerets; Mellerette; Melleril; Orsanil; Sonapax; Thioridazin; thioridazinum; tioridazina
xref: CAS:50-52-2; DrugBank:DB00679; HMDB:HMDB0014817
xref_mesh: MESH:D013881
xref: Reaxys:94457; drugcentral:2637; kegg.drug:D00373; lincs.smallmolecule:LSM-1863; pubmed:10796547; pubmed:11686961; pubmed:1650428; pubmed:17764469; pubmed:17876580; pubmed:19747949; pubmed:20825390; pubmed:26956010; pubmed:27023487; pubmed:27068340; pubmed:9352572; wikipedia.en:Thioridazine
chemrof_formula: C21H26N2S2
chemrof_smiles: CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
chemrof_inchi: InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3
chemrof_inchikey: KLBQZWRITKRQQV-UHFFFAOYSA-N
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
ISO
Thioridazine results in decreased expression of AP1S1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr12:25,261,958...25,272,483
Ensembl chr12:25,262,036...25,272,483
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Thioridazine results in increased expression of ASAH1 mRNA
CTD
PMID:17175557
NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Thioridazine results in increased expression of ASNS mRNA
CTD
PMID:17175557
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
G
Casp3
caspase 3
increases activity
ISO
Thioridazine results in increased activity of CASP3 protein
CTD
PMID:21035837
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Ccnd1
cyclin D1
decreases expression
ISO
Thioridazine results in decreased expression of CCND1 protein
CTD
PMID:21035837
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
G
Cdc25a
cell division cycle 25A
increases phosphorylation
ISO
Thioridazine results in increased phosphorylation of CDC25A protein
CTD
PMID:21035837
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Thioridazine results in decreased expression of CDK4 protein
CTD
PMID:21035837
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Thioridazine results in increased expression of CDKN1A protein
CTD
PMID:21035837
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression
ISO
Thioridazine results in increased expression of CDKN2A protein
CTD
PMID:21035837
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
G
Ces1d
carboxylesterase 1D
multiple interactions
ISO
Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]
CTD
PMID:20097249
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Thioridazine results in decreased expression of CRH mRNA
CTD
PMID:16205782
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine
CTD
PMID:19482014 PMID:23397584
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions decreases activity
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP2C19 protein
CTD
PMID:15135088 PMID:23397584
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP2D6 protein results in increased metabolism of and results in increased activity of Thioridazine
CTD
PMID:19482014 PMID:23397584
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
ISO
Thioridazine results in decreased activity of CYP2E1 protein
CTD
PMID:15135088
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions decreases activity
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP3A4 protein
CTD
PMID:15135088 PMID:23397584
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Thioridazine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases phosphorylation
ISO
Thioridazine results in decreased phosphorylation of EIF4EBP1 protein
CTD
PMID:21035837
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
G
Fabp1
fatty acid binding protein 1
increases expression
ISO
Thioridazine results in increased expression of FABP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
Thioridazine results in increased expression of FNDC4 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:30,797,102...30,800,782
Ensembl chr 6:30,796,871...30,800,769
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Thioridazine results in increased expression of GDPD3 mRNA
CTD
PMID:17175557
NCBI chr 1:190,804,053...190,813,609
Ensembl chr 1:190,803,993...190,813,606
G
Hpn
hepsin
increases expression
ISO
Thioridazine results in increased expression of HPN mRNA
CTD
PMID:15342952
NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:95,464,470...95,480,199
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Thioridazine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Thioridazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Thioridazine results in decreased activity of KCNH2 protein
CTD
PMID:15671647 PMID:16278312 PMID:21158687 PMID:24052561
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Lss
lanosterol synthase
increases expression
ISO
Thioridazine results in increased expression of LSS mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Thioridazine results in increased expression of NR0B2 mRNA
CTD
PMID:17175557
NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Thioridazine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
G
Phyh
phytanoyl-CoA 2-hydroxylase
increases expression
ISO
Thioridazine results in increased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:78,238,747...78,255,645
Ensembl chr17:78,238,747...78,255,645
G
Prl
prolactin
increases expression
ISO
Thioridazine results in increased expression of PRL protein
CTD
PMID:4065553
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
G
Serpina3n
serpin family A member 3N
increases expression
ISO
Thioridazine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Thioridazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Slc2a3
solute carrier family 2 member 3
decreases expression
ISO
Thioridazine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186
G
Tagln
transgelin
decreases expression
ISO
Thioridazine results in decreased expression of TAGLN mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563
G
Tp53
tumor protein p53
affects activity
ISO
Thioridazine affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Thioridazine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:95,042,441...95,079,293
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all